Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal

Psychoneuroendocrinology

Volumn 34, Issue 4, 2009, Pages 555-560

  Hillemacher, Thomas ^a,b   Frieling, Helge ^a   Luber, Katja ^a   Yazici, Ayfer ^a   Muschler, Marc A N ^a   Lenz, Bernd ^a   Wilhelm, Julia ^a   Kornhuber, Johannes ^a   Bleich, Stefan ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Alcohol withdrawal; ANP; Atrial natriuretic peptide; Craving; Vasopressin

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MESSENGER RNA; VASOPRESSIN;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETIC REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WITHDRAWAL SYNDROME;

ADULT; ALCOHOLISM; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REFERENCE VALUES; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; VASOPRESSINS; WATER-ELECTROLYTE BALANCE; YOUNG ADULT;

EID: 62549119106     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.10.019     Document Type: Article

References (29)

1. Anton R.F., Moak D.H., and Latham P. The obsessive compulsive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol. Clin. Exp. Res. 19 (1995) 92-99
2. Anton R.F., Moak D.H., and Latham P.K. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch. Gen. Psychiatry 53 (1996) 225-231
3. Antoni F.A., Hunter E.F., Lowry P.J., Noble J.M., and Seckl J.R. Atriopeptin: an endogenous corticotropin-release inhibiting hormone. Endocrinology 130 (1992) 1753-1755
4. Bleich S., Carl M., Bayerlein K., Reulbach U., Biermann T., Hillemacher T., Bonsch D., and Kornhuber J. Evidence of increased homocysteine levels in alcoholism: the Franconian alcoholism research studies (FARS). Alcohol. Clin. Exp. Res. 29 (2005) 334-336
5. Bleich S., Lenz B., Ziegenbein M., Beutler S., Frieling H., Kornhuber J., and Bönsch D. Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol. Clin. Exp. Res. 30 (2006) 587-591
6. Bönsch D., Lenz B., Kornhuber J., and Bleich S. DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport 16 (2005) 167-170
7. Bönsch D., Reulbach U., Bayerlein K., Hillemacher T., Kornhuber J., and Bleich S. Elevated alpha synuclein mRNA levels are associated with craving in patients with alcoholism. Biol. Psychiatry 56 (2004) 984-986
8. Döring W.K., Herzenstiel M.N., Krampe H., Jahn H., Pralle L., Sieg S., Wegerle E., Poser W., and Ehrenreich H. Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol. Clin. Exp. Res. 27 (2003) 849-861
9. Frieling H., Bleich S., Otten J., Römer K.D., Kornhuber J., de Zwaan M., Wilhelm J., and Hillemacher T. Epigenetic down-regulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity. Neuropsychopharmacology 33 (2008) 2605-2609
10. Hillemacher T., Bayerlein K., Wilhelm J., Poleo D., Frieling H., Ziegenbein M., Sperling W., Kornhuber J., and Bleich S. Volume intake and craving in alcohol withdrawal. Alcohol Alcohol. 41 (2006) 61-65
11. Hillemacher T., Bleich S., Frieling H., Schanze A., Wilhelm J., Sperling W., Kornhuber J., and Kraus T. Evidence of an association of leptin serum levels and craving in alcohol dependence. Psychoneuroendocrinology 32 (2007) 87-90
12. Hillemacher T., Frieling H., Hartl T., Wilhelm J., Kornhuber J., and Bleich S. Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. J. Psychiatr. Res. 43 (2009) 388-392
13. Hillemacher T., Kraus T., Rauh J., Weiss J., Schanze A., Frieling H., Wilhelm J., Heberlein A., Groschl M., Sperling W., Kornhuber J., and Bleich S. Role of appetite-regulating peptides in alcohol craving: an analysis in respect to subtypes and different consumption patterns in alcoholism. Alcohol. Clin. Exp. Res. 31 (2007) 950-954
14. Kaye W.H., and Weltzin T.E. Neurochemistry of bulimia nervosa. J. Clin. Psychiatry 52 Suppl. (1991) 21-28
15. Keck M.E. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Amino Acids 31 (2006) 241-250
16. Kessler M.S., Murgatroyd C., Bunck M., Czibere L., Frank E., Jacob W., Horvath C., Muigg P., Holsboer F., Singewald N., Spengler D., and Landgraf R. Diabetes insipidus and, partially, low anxiety-related behaviour are linked to a SNP-associated vasopressin deficit in LAB mice. Eur. J. Neurosci. 26 (2007) 2857-2864
17. Kiefer F., Andersohn F., Jahn H., Wolf K., Raedler T.J., and Wiedemann K. Involvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal. Acta Psychiatr. Scand. 105 (2002) 65-70
18. Kiefer F., Jahn H., Jaschinski M., Holzbach R., Wolf K., Naber D., and Wiedemann K. Leptin: a modulator of alcohol craving?. Biol. Psychiatry 49 (2001) 782-787
19. Kiefer F., Jahn H., Kellner M., Naber D., and Wiedemann K. Leptin as a possible modulator of craving for alcohol. Arch. Gen. Psychiatry 58 (2001) 509-510
20. Kristensen C.B., Rasmussen S., Dahl A., Lauritsen B., and Lund K. The withdrawal syndrome scale for alcohol and related psychoactive drugs: total scores for guidelines for treatment with Phenobarbital. Nord. Psykiatr. Tidsskr. 40 (1986) 139-146
21. Laczi F., Valkusz Z., Laszlo F.A., Wagner A., Jardanhazy T., Szasz A., Szilard J., and Telegdy G. Effects of lysine-vasopressin and 1-deamino-8-d-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients. Psychoneuroendocrinology 7 (1982) 185-193
22. Landgraf R. Neuropeptides in anxiety modulation. Handb. Exp. Pharmacol. (2005) 335-369
23. Ohashi M., Fujio N., Nawata H., Kato K., Matsubayashi S., Tamai H., Matsuo H., and Ibayashi H. Human atrial natriuretic polypeptide in plasma of patients with anorexia nervosa. Horm. Metab. Res. 20 (1988) 705-708
24. Rodenhiser D., and Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174 (2006) 341-348
25. Strohle A., Feller C., Strasburger C.J., Heinz A., and Dimeo F. Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide. Psychoneuroendocrinology 31 (2006) 1127-1130
26. Strohle A., and Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36 Suppl. 3 (2003) S207-S214
27. Strohle A., Kellner M., Holsboer F., and Wiedemann K. Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder. Am. J. Psychiatry 158 (2001) 1514-1516
28. Surget A., and Belzung C. Involvement of vasopressin in affective disorders. Eur. J. Pharmacol. 583 (2008) 340-349
29. Wiedemann K., Jahn H., Yassouridis A., and Kellner M. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch. Gen. Psychiatry 58 (2001) 371-377